(Institución)
 
 

Docu-menta > Investigación Básica > Artículos de Investigación Básica >

Por favor, use este identificador para citar o enlazar este ítem: http://documenta.ciemat.es/handle/123456789/5451

Título : Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia
Autor : Mencía, A
García, M
García, E
Llames, S
Charlesworth, A
de Lucas, R
Vicente, A
Trujillo-Tiebas, MJ
Coto, P
Costa, M
Vera, A
López-Pestaña, A
Murillas, R
Meneguzzi, G
Jorcano, JL
Conti, CJ
Escámez-Toledano, MJ
del Río, M
Palabras clave : ITGB4 mutation
Epidermolysis bullosa
genodermatoses
inherited skin diseases
pyloric atresia
Fecha de publicación : abr-2016
Editorial : Exp Dermatol.
Citación : Exp Dermatol. 2016 Apr;25(4):269-74.
Resumen : Epidermolysis bullosa with pyloric atresia (EB-PA) is a rare autosomal recessive hereditary disease with a variable prognosis from lethal to very mild. EB-PA is classified into Simplex form (EBS-PA: OMIM #612138) and Junctional form (JEB-PA: OMIM #226730), and it is caused by mutations in ITGA6, ITGB4 and PLEC genes. We report the analysis of six patients with EB-PA, including two dizygotic twins. Skin immunofluorescence epitope mapping was performed followed by PCR and direct sequencing of the ITGB4 gene. Two of the patients presented with non-lethal EB-PA associated with missense ITGB4 gene mutations. For the other four, early postnatal demise was associated with complete lack of β4 integrin due to a variety of ITGB4 novel mutations (2 large deletions, 1 splice-site mutation and 3 missense mutations). One of the deletions spanned 278 bp, being one of the largest reported to date for this gene. Remarkably, we also found for the first time a founder effect for one novel mutation in the ITGB4 gene. We have identified 6 novel mutations in the ITGB4 gene to be added to the mutation database. Our results reveal genotype-phenotype correlations that contribute to the molecular understanding of this heterogeneous disease, a pivotal issue for prognosis and for the development of novel evidence-based therapeutic options for EB management.
URI : http://documenta.ciemat.es/handle/123456789/5451
Aparece en las colecciones: Artículos de Investigación Básica

Ficheros en este ítem:

Fichero Descripción Tamaño Formato
9_Mencia_ExpDerm_2016.pdf628.39 kBAdobe PDFVisualizar/Abrir
View Statistics

Los ítems de Docu-menta están protegidos por una Licencia Creative Commons, con derechos reservados.

 

Información y consultas: documenta@ciemat.es | Documento legal